The Dark Side of Data: Power, Privacy, and the Pursuit of Precision
scientifica sessions.
Episode Description In this episode of scientifica sessions, we take an unfiltered look at the complex relationship between innovation, privacy, and power in healthcare data with Ardy Arianpour, CEO and Co-Founder of SEQSTER. The life sciences industry is overflowing with data—EHRs, genomic profiles, claims data, wearables, and AI-driven predictions—but more data doesn’t always mean better decisions. Together with host Tabari Baker, Ardy explores what happens when the pursuit of precision meets the realities of fragmentation, bias, and inequity. They unpack the hidden challenges behind...
info_outline
From Wearables to Real-World Evidence: Drew Schiller on the Future of Life Sciences
scientifica sessions.
Episode Description In this episode of scientifica sessions, we dive deep into the transformative world of real-world evidence (RWE) and patient-generated health data (PGHD) with Drew Schiller, CEO of Validic. As life sciences companies increasingly recognize the value of data from wearables, remote monitoring devices, and connected health platforms, Drew shares practical insights on how even resource-constrained startups and emerging biotechs can harness this data to drive medical strategy and support value-based care initiatives. We explore the evolving regulatory landscape, including the...
info_outline
scientifica sessions: Welcome to the Conversation
scientifica sessions.
In this inaugural episode, host Tabari Baker, Founder & CEO of kronos scientifica, introduces Scientifica Sessions—a new podcast at the intersection of science, strategy, and commercialization. With over 15 years of leadership experience in medical affairs, clinical development, and biotech commercialization, Tabari has worked with companies navigating late-stage trials, preparing for launch, and building medical organizations ready for global growth. He’s seen firsthand that great science alone isn’t enough—it takes evidence, strategy, and authentic engagement to bring innovation...
info_outline
Generative Chemogenomics & the Future of Drug Discovery: Inside AI‑Driven R&D with Tom Neyarapally
scientifica sessions.
Episode Description What if you could screen billions of potential therapies—virtually—in the time it takes to brew your morning coffee? In this episode of scientifica sessions, host Tabari Baker sits down with Tom Neyarapally, CEO and co-founder of Archetype Therapeutics, to explore how AI-native biotech is redefining what's possible in early-stage drug discovery. With a background that spans law, business, and executive leadership at companies like Sema4, Tom offers a rare vantage point on how data, machine learning, and strategic insight converge to accelerate breakthroughs in oncology...
info_outlineIn this inaugural episode, host Tabari Baker, Founder & CEO of kronos scientifica, introduces Scientifica Sessions—a new podcast at the intersection of science, strategy, and commercialization.
With over 15 years of leadership experience in medical affairs, clinical development, and biotech commercialization, Tabari has worked with companies navigating late-stage trials, preparing for launch, and building medical organizations ready for global growth. He’s seen firsthand that great science alone isn’t enough—it takes evidence, strategy, and authentic engagement to bring innovation from concept to clinic.
This episode sets the stage for what’s to come: candid conversations with scientists, biotech founders, investors, patient advocates, and industry leaders who are shaping the future of medicine. Expect clear insights, practical lessons, and stories that go beyond the headlines.
Whether you’re an executive, a founder, or simply curious about how science becomes solutions, this is your invitation to join the conversation.
Subscribe now to hear future episodes of scientifica sessions, and discover what it really takes to turn ideas into impact.
Like what you heard? Check out our producers, Thread and Tensor.
